Keqin HU
University og California Irvine, School of Medcine |
无
Professor of Clinical Medicine
School of Medicine
Director, Hepatology Services, H.H. Chao Comprehensive Digestive Disease Center
School of Medicine
M.S., Tongji Medical University, 1985, Infectious Diseases and Immunology
M.D., Tongji Medical University, 1982
Research Interests
Natural history and new treatments of viral hepatitis B and C; natural history and chemoprevention of primary liver cancer
Academic Distinctions
2019 Physicians of Excellence, Orange County Medical Association
Research Abstract
Dr. Ke-Qin Hu is the Director of Hepatology Services and Associate Professor of Clinical Medicine at UCI School of Medicine. Dr. Hu received his medical education and training in Tongji Medical University, China. He become Board Certified in Internal Medicine in US after his residency at Huntington Memorial Hospital, Pasadena, and completed a fellowship in Hepatology at the USC Liver Unit. Dr. Hu has a long-standing research interest in both basic and clinical research of viral hepatitis B and C, and primary liver cancer. Dr. Hu’s current clinical research focuses on understanding how hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is associated with fatty infiltrates in the liver and disease progression, and how viral hepatitis B and C are associated with liver cancer. As an active clinical investigator, Dr. Hu participates in several important clinical trials that tests new treatments for hepatitis B and C. Currently, his laboratory focuses on searching new chemoprevention of liver cancer. Dr. Hu has co-authored more than 100 research papers, book chapters, and review articles, including publications in Proc. Natl. Acad. Sci. USA, Journal of Clinical Investigation, and Hepatology. Dr. Hu serves as an associate editor for several medical journals.
School of Medicine
Director, Hepatology Services, H.H. Chao Comprehensive Digestive Disease Center
School of Medicine
M.S., Tongji Medical University, 1985, Infectious Diseases and Immunology
M.D., Tongji Medical University, 1982
Research Interests
Natural history and new treatments of viral hepatitis B and C; natural history and chemoprevention of primary liver cancer
Academic Distinctions
2019 Physicians of Excellence, Orange County Medical Association
Research Abstract
Dr. Ke-Qin Hu is the Director of Hepatology Services and Associate Professor of Clinical Medicine at UCI School of Medicine. Dr. Hu received his medical education and training in Tongji Medical University, China. He become Board Certified in Internal Medicine in US after his residency at Huntington Memorial Hospital, Pasadena, and completed a fellowship in Hepatology at the USC Liver Unit. Dr. Hu has a long-standing research interest in both basic and clinical research of viral hepatitis B and C, and primary liver cancer. Dr. Hu’s current clinical research focuses on understanding how hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is associated with fatty infiltrates in the liver and disease progression, and how viral hepatitis B and C are associated with liver cancer. As an active clinical investigator, Dr. Hu participates in several important clinical trials that tests new treatments for hepatitis B and C. Currently, his laboratory focuses on searching new chemoprevention of liver cancer. Dr. Hu has co-authored more than 100 research papers, book chapters, and review articles, including publications in Proc. Natl. Acad. Sci. USA, Journal of Clinical Investigation, and Hepatology. Dr. Hu serves as an associate editor for several medical journals.
The lecture video：0
Abstract：1
114
0
0
The academic assignments are as follows
| Date (UTC+8) | Time (UTC+8) | Local Time | Room | Session | Role | Talk Title |
|---|---|---|---|---|---|---|
| 2022-09-16 | 13:45-15:15 | 2022-09-16,13:45-15:15 | Meeting Room 1 |
Postgraduate Course 2 - Basic and Clinical Research in Viral Hepatitis |
Moderator |